Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.07T, Eli Lilly(LLY) trades at $1,136.78. The stock has a price-to-earnings ratio of 41.79 and currently yields dividends of 55.6%.
On 2026-06-12, Eli Lilly(LLY) stock moved within a range of $1,134.65 to $1,169.99. With shares now at $1,136.78, the stock is trading +0.2% above its intraday low and -2.8% below the session's peak.
Trading activity shows a volume of 1.49M, compared to an average daily volume of 3.43M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
LLY News
...
Key Points Pharmaceutical giant Eli Lilly's GLP-1 products and new drugs are powering its dividend growth. Parker-Hannifin is a Dividend King that has increas...
Eli Lilly’s (LLY) stock is down about 1% on June 12 as reports surface that some employers are planning to discontinue their coverage of weight-loss drugs. A r...
Analyst ratings
85%
of 33 ratingsMore LLY News
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn't make the cut. Grab the names FREE today . Eli Lilly (NYSE:LL...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study “Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Co. has begun a Phase 3 trial called “A Study of Brenipatide in...
Eli Lilly (LLY) and Company announced that the U.S. FDA approved a regimen of one maintenance dose every eight weeks of a single injection of Ebglyss for subcut...
Eli Lilly (NYSE:LLY) is moving into vaccines and infectious diseases with three acquisitions, reportedly totaling nearly $4 billion for Curevo, LimmaTech Biolog...
Swedish biotech AlzeCure Pharma announced on Tuesday a collaboration and a licensing agreement with Eli Lilly (LLY) to develop an Alzheimer’s therapy as part of...
Key Points Investors are excited about retatrutide's potential. Rival drugmakers are finding it difficult to keep pace with the healthcare leader. 10 stocks...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.